Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr ...Middle East

Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net profit of Rs 480.3 crore in the corresponding quarter last fiscal, Natco Pharma said in a regulatory filing. Consolidated revenue from operations in the first quarter was lower at Rs 735.2 crore in the first quarter as compared to Rs 1,328.9 crore in the corresponding period a year ago, it added. The decline is largely attributable to lower lenalidomide revenue in the current quarter, which was partially offset by growth in the base business, the company said. Total expenses in the quarter under review were lower at Rs 608.8 crore as compared to Rs 818.7 crore in the same period a year ago, it added. In the first quarter, domestic pharmaceutical formulations revenue was at Rs 136.4 crore, up from Rs 107 crore in the year-ago period.

Hence then, the article about natco pharma q1 results profit falls 57 to 206 cr revenue at 735 cr was published today ( Friday 14/08/2026 - 01:30 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr )

Also on site :

• Quanta Computer and Quantinuum Partner to Build an Industrial Foundation for Large-Scale Quantum Computing
• Mitratech Preparis Positioned as a Leader in the SPARK Matrix™: Business Continuity & Operational Resilience Management, 2026 by QKS Group
• Oil Prices Head for 4% Weekly Gain as U.S.-Iran Deadlock Drags On